Pharmasset, Inc. (Nasdaq: VRUS) announced the underwriters of its recent stock offering have exercised their option to purchase an additional ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE